South Korea-based Samsung Biologics continues its strategic biopharmaceutical manufacturing collaboration with AstraZene...
GenScript ProBio, the biologics contract development and manufacturing organisation (CDMO) segment of US-based GenScript...
Taiwan-based Bora Pharmaceuticals has announced a partnership with Taishin Healthcare whereby the two parties will joint...
Significant role in customer success Recognition for quality, innovation and loyalty as a strategic partner for asept...
FUJIFILM Irvine Scientific, Inc. has announced the establishment of an Innovation and Collaboration Centre in Suzhou New...
China-based WuXi STA, a subsidiary of WuXi AppTec, and Coherent Biopharma, have announced the signing of a strategic par...
ST Pharm Co. Ltd., an Active Pharmaceutical Ingredient (API) contract development and manufacturing organization (CDMO) ...
From playing a central role in combatting COVID-19 to producing the small or individual batches required in personalized...
Japan-based Meiji Seika Pharma has announced that it has been decided to construct a new manufacturing facility at Adcoc...
Japan-based Yokogawa Electric Corporation has acquired all shares of Insilico Biotechnology AG, a Germany-based develope...
WuXi Biologics has successfully launched the GMP operation of its new drug product facility located in Wuxi, China,...
MilliporeSigma, the U.S. and Canadian Life Science business of Merck KGaA, Darmstadt, Germany, a leading science an...
The 6,000 square-meter site will provide flexible clinical supply solutions, serving both local and global biotech and p...
Cytiva continues to expand its manufacturing capacity for bioprocessing single-use consumables in China. In collaboratio...
GeneQuine is developing GQ-303, its intraarticular gene therapy candidate, which turns joint cells into factories for pr...
Thermo Fisher Scientific Inc. has announced plans to establish a manufacturing facility in Nashville, US ...
ExoCoBio Inc. has announced the initiation of its "Project EGMP", starting with the construction of the world's first ex...
Expansion of clinical capacity to address growing market demand Site status now ‘ready for media fill’ N...
